UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000022530
Receipt No. R000025969
Official scientific title of the study Multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for prostate cancer
Date of disclosure of the study information 2016/05/30
Last modified on 2017/05/31 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for prostate cancer
Title of the study (Brief title) Multi-institutional study of HDR combined with EBRT for prostate cancer
Region
Japan Asia(except Japan)

Condition
Condition prostate cancer
Classification by specialty
Urology Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 to report the results of prostate cancer patients treated with high-dose-rate brachytherapy combined with external beam radiotherapy
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes biochemical disease free survival
Key secondary outcomes cumulative toxicity rate
overall survival

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male
Key inclusion criteria na
Key exclusion criteria na
Target sample size 3000

Research contact person
Name of lead principal investigator hiromichi ishiyama
Organization kitasato university school of medicine
Division name department of radiology and radiation oncology
Address 1-15-1 kitasato sagamiharashi-minamiku
TEL 042-778-8453
Email hishiyam@kitasato-u.ac.jp

Public contact
Name of contact person hiromichi ishiyama
Organization kitasato university shool of medicine
Division name department of radiology and radiation oncology
Address 1-15-1 kitasato sagamiharashi-minamiku
TEL 042-778-8453
Homepage URL
Email hishiyam@kitasato-u.ac.jp

Sponsor
Institute kitasato univerisity
Institute
Department

Funding Source
Organization Japanese Group of Brachytherapy-Japanese Society for Radiation Oncology

Japanese Radiation Oncology Study Group

Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 05 Month 30 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 10 Month 21 Day
Anticipated trial start date
2015 Year 10 Month 21 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results High-dose-rate brachytherapy combined with external beam radiotherapy was an effective and safe treatment for localized prostate cancer. Combination of long-term ADT was suggested to be necessary, even for HDR brachytherapy, and was useful in suppressing late toxicities. Meanwhile, pelvic irradiation was suggested to have an adverse effect on OS of our study population.
Other related information study design: multi-institutional retrospective analysis

Candidate: prostate cancer patients treated by high-dose-rate brachytherapy before 1995 and followed at least 2 years. Dead patients within 2 years are included.

Method: review of medical record.

Items: age, TNM stage, Gleason score, PSA value, history of TUR-p, with or without hormonal therapy, radiation dose, number of fractionations, type of external beam radiation therapy, follow up period, tumor control, survival period, toxicity rate

Management information
Registered date
2016 Year 05 Month 30 Day
Last modified on
2017 Year 05 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025969